Article Text

Download PDFPDF

Investigation of loss of heterozygosity at specific loci on chromosomes 3p, 6q, 11p, 17p and 17q in ovarian cancer
  1. J. A. Leary,
  2. C. P. Doris*,
  3. E. M. Boltz*,
  4. C. R.S. Houghton,
  5. R. F. Kefford* and
  6. M. L. Friedlander
  1. * Departments of Medical Oncology and
  2. Obstetrics and Gynaecology, University of Sydney, Westmead Centre, Westmead, NSW; and Department of
  3. Medical Oncology, Prince of Wales Hospital, High Street, Randwick, NSW, Australia
  1. Address for correspondence: M.L. Friedlander, Department of Medical Oncology, Prince of Wales Hospital, High Street, Randwick, NSW, Australia.

Abstract

In an attempt to further define the genetic events in the pathogenesis and progression of human ovarian cancer, an analysis of constitutional and ovarian carcinoma DNA samples revealed loss of heterozygosity (LOH) at specific loci on chromosomes 3p (38%), 6q (23%), 11p (33%), 17p (82%) and 17q (62%). In contrast, LOH was not observed in benign or borderline tumors. No significant association could be demonstrated between LOH at the loci studied and tumor stage, histologic subtype, grade or patient outcome. Further analyses of large tumor panels are now required to determine the relationship between LOH at these loci and the clinicopathological behavior of ovarian tumors.

  • allele loss
  • loss of heterozygosity
  • ovarian carcinoma.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.